‘Darkhorse’ Vaccine Developer in San Diego Quietly Gains Global Attention in COVID-19 Fight
If the pursuit of a COVID-19 vaccine were a horse race, a company in San Diego is either the Seabiscuit or darkhorse candidate to win.
With a newly acquired $173 million dollars from Wall Street after a public stock offering, Arcturus Therapeutics Holdings ...
